Drug recall · July 9, 2014
Brevibloc Premixed Injection recall
Why: Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.
- Lots / codes
Lot #: C926923, Exp 01/16
- Quantity
- 20,810 containers
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide
- Initiated
- June 16, 2014 · Voluntary: Firm initiated
- Classified
- July 1, 2014
- Reported
- July 9, 2014
- Ended
- April 10, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Esmolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.